Pentwater Capital Management’s Pandion Therapeutics Inc. Common Stock PAND Stock Holding History

Pentwater Capital Management’s Portfolio PAND Stock Details PAND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-150,000	Closed	-$9.01M	–	435
2021 Q1	$9.01M	Buy	+150,000	New	+$5.43M	0.09%	86

Pentwater Capital Management's PAND Position: Q2 2021 in Review

Pentwater Capital Management sold out of Pandion Therapeutics Inc. Common Stock (PAND) in Q2 2021, closing a stake of 150,000 shares — an estimated $9.01M sold.

Pentwater Capital Management first reported a position in PAND in Q1 2021 and held it in 1 quarter. The position peaked at $9.01M in Q1 2021. 0 funds tracked by Wall St. Rank hold PAND as of Q2 2021.

Pentwater Capital Management reported no remaining Pandion Therapeutics Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
Pentwater Capital Management sold 150,000 Pandion Therapeutics Inc. Common Stock shares in Q2 2021, an estimated $9.01M.
Pentwater Capital Management first reported a position in Pandion Therapeutics Inc. Common Stock in Q1 2021 and held it in 1 quarter.
Pentwater Capital Management's Pandion Therapeutics Inc. Common Stock position peaked at $9.01M in Q1 2021.
0 funds tracked by Wall St. Rank held Pandion Therapeutics Inc. Common Stock as of Q2 2021.

Based on Pentwater Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.